Bohan Ma
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
-
- Protein Degradation and Inhibitors
- RNA Interference and Gene Delivery
- Ubiquitin and proteasome pathways
- Advanced biosensing and bioanalysis techniques
- Melanoma and MAPK Pathways
Papers in
-
- Protein Degradation and Inhibitors 9
- Ubiquitin and proteasome pathways 4
- Melanoma and MAPK Pathways 3
- Advanced biosensing and bioanalysis techniques 3
- Oncology 13
- Peptidase Inhibition and Analysis 9
- Co-authors
- Yongping Shao (8 shared papers)Wangxiao He (6 shared papers)Wuyuan Lu (6 shared papers)F. Niu (6 shared papers)Jin Yan (4 shared papers)X. Peter (3 shared papers)Yizeng Fan (10 shared papers)Bo Lei (3 shared papers)
- Journals
- International Journal of Biological Macromolecules (3 papers)Advanced Science (3 papers)Scientific Reports (2 papers)Nature Communications (2 papers)Theranostics (2 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Bohan Ma
41 papers receiving 911 citations
Peers
Comparison fields: 5 of 97
- Biomaterials 175
- Molecular Biology 537
- Microbiology 44
- Oncology 190
- Biomedical Engineering 233
Countries citing papers authored by Bohan Ma
This map shows the geographic impact of Bohan Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bohan Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bohan Ma more than expected).
Fields of papers citing papers by Bohan Ma
This network shows the impact of papers produced by Bohan Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bohan Ma. The network helps show where Bohan Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Bohan Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 115 | |
| 2 | 2017 | 112 | |
| 3 | 2018 | 67 | |
| 4 | 2017 | 63 | |
| 5 | 2022 | 58 | |
| 6 | 2021 | 57 | |
| 7 | 2018 | 39 | |
| 8 | 2022 | 37 | |
| 9 | 2019 | 35 | |
| 10 | 2011 | 29 | |
| 11 | 2019 | 28 | |
| 12 | 2022 | 26 | |
| 13 | 2022 | 25 | |
| 14 | 2018 | 21 | |
| 15 | 2021 | 19 | |
| 16 | 2024 | 19 | |
| 17 | 2024 | 19 | |
| 18 | 2022 | 17 | |
| 19 | 2019 | 16 | |
| 20 | 2024 | 14 |
About Bohan Ma
Bohan Ma is a scholar working on Molecular Biology, Oncology, Biomedical Engineering, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 44 papers that have together received 919 indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (9 papers), Peptidase Inhibition and Analysis (9 papers), Nanoplatforms for cancer theranostics (5 papers), Ubiquitin and proteasome pathways (4 papers), Melanoma and MAPK Pathways (3 papers), Nanoparticle-Based Drug Delivery (3 papers), Multiple Myeloma Research and Treatments (3 papers) and Advanced biosensing and bioanalysis techniques (3 papers). The work is most often cited by research in Biomaterials (175 citations), Molecular Biology (537 citations), Microbiology (44 citations), Oncology (190 citations) and Biomedical Engineering (233 citations). Bohan Ma has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Yongping Shao, Wangxiao He, Wuyuan Lu, F. Niu, Jin Yan, X. Peter, Yizeng Fan, Bo Lei, Penghui Zhang and Yaping Du. Their work appears in journals such as International Journal of Biological Macromolecules, Advanced Science, Scientific Reports, Nature Communications and Theranostics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.